Novartis Seeks To Block Alleged Infringer Of Votrient Patent In India

 
• By Anju Ghangurde

Just months ahead of the patent expiry for Votrient in India, Novartis hauls alleged infringer MSN Laboratories to court, which has bound the Indian firm by its pre-launch assurance for the anticancer therapy.

patents
Votrient Patent Infringement Case In Indian Court • Source: Alamy

More from India

More from Focus On Asia